α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro
Top Cited Papers
- 8 May 2001
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 30 (10), 1163-1170
- https://doi.org/10.1016/s0891-5849(01)00513-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Induction of neuronal death by α‐synucleinEuropean Journal of Neuroscience, 2000
- Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjectsNeuroscience Letters, 2000
- α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque coresNeuroscience Letters, 1999
- Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filamentsFEBS Letters, 1998
- Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's diseaseFEBS Letters, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloidsFEBS Letters, 1995
- Identification of two distinct synucleins from human brainFEBS Letters, 1994